Treating Symptoms of Long COVID with Stella's Dual Sympathetic Reset (DSR)
Medical professionals continue to innovate as we learn more about how COVID-19 can impact the body in the long term. While early papers, case studies, and trials have provided helpful information about Long Covid, more research needs to be conducted. However, there have been cases treated by Stella that have shown significant improvement.
DSR SGB for Long COVID
Stella Certified Doctor Dr. Luke D. Liu and Research Coordinator Deborah L. Duricka recently added to this body of knowledge with their study, Stellate ganglion block reduces symptoms of Long COVID: A case series. This study explains how the Dual Sympathetic Reset, also referred to as the Stellate Ganglion Block (SGB) successfully reduced two individuals' long COVID symptoms.
During DSR, local anesthetic is injected, which temporarily blocks or "turns off" the nerves it's injected into which can help restore normal biological functions.
After the individuals were treated with the Dual Sympathetic Reset, both experienced relief in symptoms like debilitating fatigue, mental fogginess, difficulty concentrating, elevated resting heart rate, sleep disturbance, altered sense of taste and smell, and lack of appetite and food aversion due to changes in taste and smell.
Dual Sympathetic Reset's application in treating Long-COVID is novel but promising. And, the lack of effective treatments for Long-COVID makes the DSR an attractive therapeutic modality that deserves further investigation.
Studies like this help further the evidence that DSR treatment impacts sleep and trauma-related symptoms.